WK Cancer Treatement Center

Clinical Trials

An Observational Evaluation in Multiple Myeloma (MM)


To better understand the clinical effectiveness of therapies used in treating relapsed/refractory multiple myeloma (MM) in the real-world clinical practice.


  • Diagnosed with relapse or refractory Multiple Myeloma (MM)
  • Received at least one prior treatment of therapy for MM
  • Age of 18 years or older
  • Have documented progression from most recent line of therapy
  • Not currently participating in a clinical trial for MM


  • Subjects will be followed every 3 months while participating

Interested in Volunteering for the Study?

If you would like more information about this study, please call us at (318) 212-8671.